FDA Unveils New Office of Science and Innovation

Delivering on her promise to promote regulatory science to help drugmakers get their treatments to market faster, FDA Commissioner Margaret Hamburg announced the agency will establish an Office of Science and Innovation. The office, which will be housed within the Office of the Chief Scientist, will develop strategic plans, track outcomes, organize scientific collaborations and monitor outside partnerships with input from a new strategic advisory council and the Science Board, Hamburg said as she unveiled an FDA Regulatory Science Initiative report this week.
Drug Industry Daily